These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. Mas JL; Arquizan C; Lamy C; Zuber M; Cabanes L; Derumeaux G; Coste J; N Engl J Med; 2001 Dec; 345(24):1740-6. PubMed ID: 11742048 [TBL] [Abstract][Full Text] [Related]
5. [Patent foramen ovale. What is it and what does it indicate?]. Serena J Neurologia; 2006 Dec; 21(10):689-94. PubMed ID: 17106821 [TBL] [Abstract][Full Text] [Related]
6. [Percutaneous closure of patent foramen ovale, as secondary prevention of cryptogenic cerebral event]. Temesvári A; Bálint OH; Liptai C; Kancz S; Németh B; Szatmári A Orv Hetil; 2006 Oct; 147(42):2035-9. PubMed ID: 17165604 [TBL] [Abstract][Full Text] [Related]
7. [Anomalties of the interatrial septum and latent atrial vulnerability in unexplained ischemic stroke in young adults]. Somody E; Albucher JF; Casteignau G; Prouteau N; Danielli A; Delay M; Chollet F; Puel J Arch Mal Coeur Vaiss; 2000 Dec; 93(12):1495-500. PubMed ID: 11211443 [TBL] [Abstract][Full Text] [Related]
8. A new theory of cryptogenic stroke and its relationship to patent foramen ovale; or, the puzzle of the missing extra risk. Eggers AE Med Hypotheses; 2006; 67(5):1072-5. PubMed ID: 16814938 [TBL] [Abstract][Full Text] [Related]
9. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Thanopoulos BV; Dardas PD; Karanasios E; Mezilis N Catheter Cardiovasc Interv; 2006 Nov; 68(5):741-6. PubMed ID: 17039525 [TBL] [Abstract][Full Text] [Related]
10. [Percutaneous closure of patent foramen ovale-- Against]. Schneider CA Dtsch Med Wochenschr; 2006 Apr; 131(14):771. PubMed ID: 16596498 [No Abstract] [Full Text] [Related]
11. Spontaneous large right-to-left shunt and migraine headache with aura are risk factors for recurrent stroke in patients with a patent foramen ovale. Giardini A; Donti A; Formigari R; Salomone L; Palareti G; Guidetti D; Picchio FM Int J Cardiol; 2007 Sep; 120(3):357-62. PubMed ID: 17166607 [TBL] [Abstract][Full Text] [Related]
12. [Options in the management of persistent foramen ovale after an ischemic stroke]. Haberl R Dtsch Med Wochenschr; 2006 Nov; 131 Suppl 5():S126-8. PubMed ID: 17089256 [No Abstract] [Full Text] [Related]
13. Patent foramen ovale and cryptogenic stroke: a complex neuro-cardio-vascular problem. Spies C; Wong M Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1455-67. PubMed ID: 19900028 [TBL] [Abstract][Full Text] [Related]
14. Patent foramen ovale and the risk of cryptogenic stroke. Schrale RG; Mitchell AR; Ormerod OJ J Am Coll Cardiol; 2006 Nov; 48(9):1913-4; author reply 1914. PubMed ID: 17084271 [No Abstract] [Full Text] [Related]
15. [Thrombophilia and patent foramen ovale in young stroke patients]. Carod-Artal FJ; Vilela Nunes S; Portugal D Neurologia; 2006 Dec; 21(10):710-6. PubMed ID: 17106824 [TBL] [Abstract][Full Text] [Related]
16. Patent foramen ovale and cryptogenic stroke. Kizer JR Am J Med; 2007 Dec; 120(12):e13; author reply e15. PubMed ID: 18060903 [No Abstract] [Full Text] [Related]
17. Outcomes after transcatheter closure of patent foramen ovale in patients with paradoxical embolism. Harms V; Reisman M; Fuller CJ; Spencer MP; Olsen JV; Krabill KA; Gray WA; Jesurum JT Am J Cardiol; 2007 May; 99(9):1312-5. PubMed ID: 17478164 [TBL] [Abstract][Full Text] [Related]